/ flu shot
/ Market Analysis
Moderna’s Shares Gain in Premarket as New Flu Shot Shows Promising Results
Moderna's experimental flu vaccine demonstrated superior efficacy compared to standard flu vaccines in late-stage trials.
June 30, 2025